ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
0.3650
-0.0150 (-3.95%)
At close: Apr 25, 2025, 4:00 PM
0.3614
-0.0036 (-0.99%)
After-hours: Apr 25, 2025, 7:27 PM EDT

ReShape Lifesciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
43532920
Upgrade
Market Cap Growth
-31.26%-31.26%41.89%-88.83%47.08%882.72%
Upgrade
Enterprise Value
433-3328
Upgrade
Last Close Price
0.364.4614.48390.924755.9910294.99
Upgrade
PS Ratio
0.020.400.530.292.141.76
Upgrade
PB Ratio
-16.27-12.560.690.890.661.37
Upgrade
P/TBV Ratio
--0.690.961.24-
Upgrade
EV/Sales Ratio
0.550.330.40-0.252.50
Upgrade
Debt / Equity Ratio
-3.82-3.820.040.050.010.92
Upgrade
Asset Turnover
1.041.040.800.350.300.30
Upgrade
Inventory Turnover
0.950.950.851.342.002.83
Upgrade
Quick Ratio
0.340.341.620.813.400.48
Upgrade
Current Ratio
0.920.922.731.333.980.77
Upgrade
Return on Equity (ROE)
-222.47%-222.47%-220.59%-192.58%-214.70%-112.09%
Upgrade
Return on Assets (ROA)
-53.93%-53.93%-83.92%-53.16%-34.82%-20.30%
Upgrade
Return on Capital (ROIC)
-109.11%-109.11%-170.11%-69.87%-43.11%-27.20%
Upgrade
Earnings Yield
-173.23%-224.32%-246.26%-1418.17%-216.52%-109.09%
Upgrade
FCF Yield
-107.56%-139.28%-367.72%-676.13%-53.93%-45.09%
Upgrade
Buyback Yield / Dilution
-401.98%-401.98%----
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q